Kamath AM, Schaefer AM, Palmisano EB, et al. - Researchers conducted a pre-post study at 166 basic-level and comprehensive-level health facilities in Belize, Guatemala, Honduras, Mexico, Nicaragua and Panama in order to determine the availability and administration of oxytocin, before and after application of Salud Mesoamérica Initiative interventions in the poorest health facilities across Central America. Assessment was performed of a random sample of medical records for uncomplicated full-term deliveries (n = 2,470) at baseline (July 2011 to August 2013) and at first-phase follow-up (January 2014 to October 2014). The study revealed a significant improvement in availability but not administration of oxytocin in poor communities within Mesoamerica after interventions to raise health facility supplies. This emphasize improving efforts to enhance the use of oxytocin.